Press Releases

January 31, 2023

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

Read More
December 12, 2022

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

Read More
November 22, 2022

MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS

Read More
August 5, 2022

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

Read More
July 29, 2022

Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay

Read More
July 7, 2022

Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

Read More
July 7, 2022

Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter

Read More
June 20, 2022

Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays

Read More
May 29, 2022

Meridian Bioscience Launches Lyo-Ready qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection

Read More
May 26, 2022

Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests

Read More